Insider at

04

Insider transactions

05
0 buys (P) 0 sells (S) Net: $0 + 29 non-open-market transactions below last 12 months, based on the transactions shown below

Price change vs current quote, split-adjusted for corporate actions since the filing — not benchmarked, not annualized, not size-weighted

29 other filings hidden
DateTickerCodeSharesPriceValue Owned afterΔ ownA/Dvs now
May 30, 2023 XWEL P 25,000 $0.25 $6,250 156,485 Direct +19.01% Acquired -83.2% (price as of 2026-10-02)
May 26, 2023 XWEL P 25,000 $0.25 $6,250 131,485 Direct +23.48% Acquired -83.2% (price as of 2026-10-02)
Dec. 16, 2022 TAOX S 10b5-1 27,000 $1.17 $31,590 33,198 Direct -44.85% Disposed -84.9% (price as of 2026-10-02)
April 20, 2022 XWEL S 10b5-1 45,000 $1.06 $47,700 106,485 Direct -29.71% Disposed -96.0% (price as of 2026-10-02)
Jan. 19, 2022 XWEL S 10b5-1 45,000 $1.56 $70,200 120,235 Direct -27.23% Disposed -97.3% (price as of 2026-10-02)
Sept. 20, 2021 XWEL S 10b5-1 63,000 $1.43 $90,090 165,235 Direct -27.60% Disposed -97.1% (price as of 2026-10-02)

P = Open-market purchase · S = Sale · A = Grant/award · M = Option exercise · G = Gift · F = Tax withholding

Insider transactions are not a recommendation; sales are often driven by liquidity or tax reasons.

Derivative holdings (Form 4 Table II) Options, RSUs and convertible securities reported on Form 4 Table II.

06
DateTickerSecurityUnderlying Exercise priceExpirationSharesA/D
May 18, 2026 TAOX Stock Option (Right to Buy) Common Stock, par value $0.0001 per share (30,000) $4.80 May 18, 2036 30,000 Acquired
March 31, 2026 PMCB Stock Option (Right to Buy) [F1] Common Stock [F1] · · 0 Acquired
March 31, 2026 PMCB Stock Option (Right to Buy) Common Stock (119,170) $0.67 March 30, 2036 119,170 Acquired
Aug. 6, 2025 TAOX Employee Stock Option (right to buy) Common Stock (7,000) $10.38 July 14, 2035 7,000 Acquired
June 2, 2025 XWEL Employee stock option (right to buy) [F2] Common Stock (117,886) $0.97 June 2, 2035 117,886 Acquired
April 25, 2025 PMCB Stock Option (Right to Buy) Common Stock (63,233) $1.22 April 24, 2035 63,233 Acquired
Nov. 15, 2024 XWEL Employee stock option (right to buy) [F1] Common Stock (30,825) $1.65 Nov. 15, 2034 30,825 Acquired
April 30, 2024 PMCB Stock Option (Right to Buy) Common Stock (38,009) $2.12 April 30, 2034 38,009 Acquired
Nov. 20, 2023 PMCB Stock Option (Right to Buy) Common Stock (61,248) $2.18 Nov. 20, 2033 61,248 Acquired
Jan. 5, 2023 XWEL Stock Option (right to buy) [F1] Common Stock (300,000) $0.40 Jan. 5, 2033 300,000 Acquired
Jan. 5, 2023 XWEL Stock Option (right to buy) [F1] Common Stock (300,000) $0.33 Jan. 5, 2033 300,000 Acquired
Nov. 15, 2022 TAOX Stock Option (Right to Buy) Common Stock, par value $0.0001 per share (75,000) $6.07 Nov. 15, 2032 75,000 Acquired
Nov. 15, 2022 TAOX Stock Option (Right to Buy) Common Stock, par value $0.0001 per share (96,000) $6.07 Nov. 15, 2032 96,000 Acquired
Jan. 26, 2022 XWEL Stock Option (right to buy) [F1] Common Stock (46,875) $1.28 Jan. 26, 2032 46,875 Acquired
Jan. 4, 2021 XWEL Stock Option (right to buy) [F1] Common Stock (43,077) $1.19 Jan. 4, 2031 43,077 Acquired
April 20, 2020 XWEL Stock Option (Right to Buy) [F1] Common Stock (185,000) $0.51 April 20, 2030 185,000 Acquired

Exercise/conversion price is blank when not applicable (e.g. RSUs).

Initial ownership (Form 3) 3 holdings

07

Securities held when first becoming an insider, per SEC Form 3.

DateTickerSecuritySharesOwnership
June 14, 2021 TAOX Common Stock, par value $0.0001 per share 198 Direct
June 14, 2021 TAOX Warrant (Right to Buy)→ Common Stock, par value $0.0001 per share (66) 66 Direct
June 14, 2021 TAOX Stock Option (Right to Buy)→ Common Stock, par value $0.0001 per share (11,125) 11,125 Direct

Compensation (DEF 14A)

08

Matched by name from proxy statements (DEF 14A) — verify against the filing.

TAOX

EVP
Fiscal yearSalaryBonusStock awards Option awardsNon-equity incentivePension changeOtherTotal
2022 $318,830 $150,000 · · · · $52,053 $883,344
2021 $300,780 $150,000 $585,000 · · · $54,265 $1,184,751

Figures from the Summary Compensation Table of the company's proxy statement (DEF 14A). Compensation is not a recommendation.